Publication | Closed Access

The synthesized transporter K16APoE enabled the therapeutic HAYED peptide to cross the blood-brain barrier and remove excess iron and radicals in the brain, thus easing Alzheimer’s disease

Neurodegenerative DiseasesNeuropeptidesAlzheimer's DiseaseMedicineExcess IronSynthesized Transporter K16apoeNeuropharmacologyDegenerative PathologyNeuroprotectionNeurologyNeuroscienceTherapeuticsPharmacologyTherapeutic Hayed PeptideOxidative StressNeuroinflammation